This invention provides a novel class of 3-methyleneazetidines which include diphenylmethyl derivatives such as 1-isopropyl-3-diphenylmethyleneazetidine oxalate: ##STR1## This illustrated 3-methyleneazetidine compound is characterized by a combination of pharmacological properties which are indicative of utility as a mood elevating therapeutic agent for relieving the symptoms of depression in humans. The illustrated compound exhibits an ED.sub.50 (tetrabenazine-induced ptosis) of 2.18 mg/kg in mice.
这项发明提供了一种新的3-亚甲基氮
杂环化合物类,其中包括二苯甲基衍
生物,如1-异丙基-3-二苯甲基氮杂环
乙二酸盐:##STR1## 这种展示的3-亚甲基氮
杂环化合物的特点是具有一种药理学性质的组合,表明其作为一种情绪提升的治疗剂在缓解人类抑郁症状方面具有实用性。这种展示的化合物在小鼠中表现出ED.sub.50(四
苯丙嗪诱导的眼睑下垂)为2.18mg/kg。